These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12038703)

  • 41. Prevalence of ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women.
    Giacomazzi J; Aguiar E; Palmero EI; Schmidt AV; Skonieski G; Filho DD; Bock H; Saraiva-Pereira ML; Ewald IP; Schuler-Faccini L; Camey SA; Caleffi M; Giugliani R; Ashton-Prolla P
    Braz J Med Biol Res; 2012 Oct; 45(10):891-7. PubMed ID: 22584640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemistry subtypes (ER/PR/HER) of breast cancer: where do we stand in the West of Saudi Arabia?
    Khabaz MN
    Asian Pac J Cancer Prev; 2014; 15(19):8395-400. PubMed ID: 25339035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The progins progesterone receptor gene polymorphism is not related to endometriosis-associated infertility or to idiopathic infertility.
    Gimenes C; Bianco B; Mafra FA; Rosset V; Christofolini DM; Barbosa CP
    Clinics (Sao Paulo); 2010; 65(11):1073-6. PubMed ID: 21243274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
    Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients.
    Duman BB; Afşar ÇU; Günaldi M; Sahin B; Kara IO; Erkisi M; Erçolak V
    Asian Pac J Cancer Prev; 2012; 13(8):4119-23. PubMed ID: 23098527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50.
    Wang-Gohrke S; Chang-Claude J; Becher H; Kieback DG; Runnebaum IB
    Cancer Res; 2000 May; 60(9):2348-50. PubMed ID: 10811106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer.
    Karsten M; Stempel M; Radosa J; Patil S; King TA
    Ann Surg Oncol; 2016 Feb; 23(2):471-6. PubMed ID: 26340863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer.
    Gabra H; Langdon SP; Watson JE; Hawkins RA; Cohen BB; Taylor L; Mackay J; Steel CM; Leonard RC; Smyth JF
    Clin Cancer Res; 1995 Sep; 1(9):945-53. PubMed ID: 9816065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The progesterone receptor gene polymorphism, PROGINS, may be a factor related to the development of uterine fibroids.
    Gomes MT; Castro Rde A; Villanova FE; da Silva ID; Baracat EC; de Lima GR; Girão MJ
    Fertil Steril; 2007 May; 87(5):1116-21. PubMed ID: 17224149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.
    Sayed S; Moloo Z; Wasike R; Bird P; Oigara R; Govender D; Kibera J; Carrara H; Saleh M
    Breast; 2014 Oct; 23(5):591-6. PubMed ID: 25012047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
    Beaty MW; Quezado M; Sobel ME; Duray P; Merino MJ
    Int J Surg Pathol; 2005 Jan; 13(1):9-18. PubMed ID: 15735850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer.
    Mao H; Qu X; Yang Y; Zuo W; Bi Y; Zhou C; Yin H; Deng B; Sun J; Zhang L
    Mol Carcinog; 2010 Mar; 49(3):283-9. PubMed ID: 19937980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion.
    Rowe SM; Coughlan SJ; McKenna NJ; Garrett E; Kieback DG; Carney DN; Headon DR
    Cancer Res; 1995 Jul; 55(13):2743-5. PubMed ID: 7796397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women.
    Chuthapisith S; Permsapaya W; Warnnissorn M; Akewanlop C; Sirivatanauksorn V; Prasarttong Osoth P
    Asian Pac J Cancer Prev; 2012; 13(2):459-62. PubMed ID: 22524806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer.
    Rahimi Z; Yari K; Rahimi Z
    Asian Pac J Cancer Prev; 2015; 16(3):1175-9. PubMed ID: 25735351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.